ArticleFrontiers in neurology2025

Efgartigimod non-responders after the first treatment cycle in generalized myasthenia gravis: a retrospective analysis of predictive factors.

Zhenyu Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.